- Home
- SNY vs COP Comparison
SNY vs COP Comparison
Compare SNY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | COP |
|---|---|---|
| Founded | 1994 | 1917 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5B | 162.0B |
| IPO Year | 2001 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SNY | COP |
|---|---|---|
| Price | $45.70 | $133.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 23 |
| Target Price | $58.00 | ★ $123.65 |
| AVG Volume (30 Days) | 3.1M | ★ 6.5M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.47% | 2.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.00 |
| Revenue | N/A | ★ $58,944,000,000.00 |
| Revenue This Year | $3.49 | $6.88 |
| Revenue Next Year | $6.10 | N/A |
| P/E Ratio | ★ $6.14 | $26.50 |
| Revenue Growth | N/A | ★ 7.67 |
| 52 Week Low | $40.89 | $85.59 |
| 52 Week High | $52.68 | $135.88 |
Technical Indicators
Market Signals| Indicator | SNY | COP |
|---|---|---|
| Relative Strength Index (RSI) | 62.36 | 69.17 |
| Support Level | $43.28 | $113.24 |
| Resistance Level | $48.66 | $135.87 |
| Average True Range (ATR) | 0.54 | 3.22 |
| MACD | 0.25 | 0.98 |
| Stochastic Oscillator | 86.80 | 88.33 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated liquefied natural gas production and marketing activities across geographies.